Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1999
DOI: 10.1016/s0168-3659(99)00007-3
|View full text |Cite
|
Sign up to set email alerts
|

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
181
0
1

Year Published

2003
2003
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 422 publications
(188 citation statements)
references
References 22 publications
1
181
0
1
Order By: Relevance
“…In vitro ZMT release profile of selected nanoparticles was determined using dialysis membrane in USP II dissolution apparatus (Yang et al, 1999). The nanoparticles were kept in dialysis membrane-150 with a molecular weight cut-off of range of 12 -14 kDa (Hi-Media, Mumbai, India) and tied with rotating paddle at 100 rpm.…”
Section: In-vitro Drug Release Studiesmentioning
confidence: 99%
“…In vitro ZMT release profile of selected nanoparticles was determined using dialysis membrane in USP II dissolution apparatus (Yang et al, 1999). The nanoparticles were kept in dialysis membrane-150 with a molecular weight cut-off of range of 12 -14 kDa (Hi-Media, Mumbai, India) and tied with rotating paddle at 100 rpm.…”
Section: In-vitro Drug Release Studiesmentioning
confidence: 99%
“…Tumour targetinghas been achieved with SLNs loaded with drugs like methotrexate [23] and Camptothecin [24].Tamoxifen an anticancer drug is incorporated inSLN to prolong release of drug after i.v.…”
Section: Slns As a Targeted Carrier For Anticancer Drugto Solid Tumorsmentioning
confidence: 99%
“…In vitro release profile of MFA from formulations was determined using the dialysis bag technique (Sigma, USA; MWCO 12000-14000) (Yang et al, 1999). Because of the low solubility of MFA in water and acetate buffer (pH 6.0), acetate buffer (pH 6.0) with 1% w/v cetyltrimethylammonium bromide (CTAB) was selected as acceptor medium.…”
Section: In Vitro Releasementioning
confidence: 99%